Bumper Offer - Urjas oil Just @ Rs. 1
Hyocimax S 0.375 Tablet CR is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Abdominal Pain. Secondary and off-label uses of Hyocimax S 0.375 Tablet CR have also been mentioned below.
The optimal dosage of Hyocimax S 0.375 Tablet CR is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Hyocimax S 0.375 Tablet CR as well, which are listed below. These side effects of Hyocimax S 0.375 Tablet CR are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Hyocimax S 0.375 Tablet CR's effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Hyocimax S 0.375 Tablet CR related warnings talks about Hyocimax S 0.375 Tablet CR's effects on the liver, heart and kidney.
Hyocimax S 0.375 Tablet CR is contraindicated in people with pre-existing medical conditions like Myasthenia Gravis (MG), GERD (Gastroesophageal Reflux Disease) as it can result in adverse effects. The section on Hyocimax S 0.375 Tablet CR contraindications lists all such conditions.
Besides this, Hyocimax S 0.375 Tablet CR may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Hyocimax S 0.375 Tablet CR is considered not safe while driving, and is not addictive.
Hyocimax S 0.375 Tablet CR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Hyocimax S 0.375 Tablet CR is used -
Moderate
Mild
Is the use of Hyocimax S 0.375 Tablet CR safe for pregnant women?
Hyocimax can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Hyocimax right away. Take your doctor's advice before taking it again.
Is the use of Hyocimax S 0.375 Tablet CR safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Hyocimax. Immediately discontinue Hyocimax if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Hyocimax S 0.375 Tablet CR on the Kidneys?
Very few cases of side effects of Hyocimax on kidney have been reported.
What is the effect of Hyocimax S 0.375 Tablet CR on the Liver?
Hyocimax is rarely harmful for the liver.
What is the effect of Hyocimax S 0.375 Tablet CR on the Heart?
Very few cases of side effects of Hyocimax on the heart have been reported.
Hyocimax S 0.375 Tablet CR should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Unknown
If you are suffering from any of the following diseases, you should not take Hyocimax S 0.375 Tablet CR unless your doctor advises you to do so -
Is this Hyocimax S 0.375 Tablet CR habit forming or addictive?
Hyocimax S 0.375 Tablet CR is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Hyocimax S 0.375 Tablet CR can make you feel drowsy.
Is it safe?
Yes, but take Hyocimax S 0.375 Tablet CR only as per medical advice.
Is it able to treat mental disorders?
Hyocimax S 0.375 Tablet CR is unable to treat or cure mental disorders.
Interaction between Food and Hyocimax S 0.375 Tablet CR
Taking Hyocimax S 0.375 Tablet CR with food is safe.
Interaction between Alcohol and Hyocimax S 0.375 Tablet CR
Consuming Hyocimax S 0.375 Tablet CR with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1403
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Transderm scop (scopolamine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1403
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Transderm scop (scopolamine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1403
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Transderm scop (scopolamine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1403
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Transderm scop (scopolamine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1403
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Transderm scop (scopolamine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1403
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Transderm scop (scopolamine)